Literature DB >> 11246888

Direct regulatory effect of fatty acids on macrophage lipoprotein lipase: potential role of PPARs.

S E Michaud1, G Renier.   

Abstract

Atherosclerosis is a major complication of type 2 diabetes. The pathogenesis of this complication is poorly understood, but it clearly involves production in the vascular wall of macrophage (Mo) lipoprotein lipase (LPL). Mo LPL is increased in human diabetes. Peripheral factors dysregulated in diabetes, including glucose and free fatty acids (FAs), may contribute to this alteration. We previously reported that high glucose stimulates LPL production in both J774 murine and human Mo. In the present study, we evaluated the direct effect of FAs on murine Mo LPL expression and examined the involvement of peroxisome proliferator-activated receptors (PPARs) in this effect. J774 Mo were cultured for 24 h with 0.2 mmol/l unsaturated FAs (arachidonic [AA], eicosapentaenoic [EPA], and linoleic acids [LA]) and monounsaturated (oleic acid [OA]) and saturated FAs (palmitic acid [PA] and stearic acid [SA]) bound to 2% bovine serum albumin. At the end of this incubation period, Mo LPL mRNA expression, immunoreactive mass, activity, and synthetic rate were measured. Incubation of J774 cells with LA, PA, and SA significantly increased Mo LPL mRNA expression. In contrast, exposure of these cells to AA and EPA dramatically decreased this parameter. All FAs, with the exception of EPA and OA, increased extra- and intracellular LPL immunoreactive mass and activity. Intracellular LPL mass and activity paralleled extracellular LPL mass and activity in all FA-treated cells. In Mo exposed to AA, LA, and PA, an increase in Mo LPL synthetic rate was observed. To evaluate the role of PPARs in the modulatory effect of FAs on Mo LPL gene expression, DNA binding assays were performed. Results of these experiments demonstrate an enhanced binding of nuclear proteins extracted from all FA-treated Mo to the peroxisome proliferator-response element (PPRE) consensus sequence of the LPL promoter. PA-, SA-, and OA-stimulated binding activity was effectively diminished by immunoprecipitation of the nuclear proteins with anti-PPAR-alpha antibodies. In contrast, anti-PPAR-gamma antibodies only significantly decreased AA-induced binding activity. Overall, these results provide the first evidence for a direct regulatory effect of FAs on Mo LPL and suggest a potential role of PPARs in the regulation of Mo LPL gene expression by FAs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11246888     DOI: 10.2337/diabetes.50.3.660

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  21 in total

1.  Peroxisome proliferator-activated receptor subtype- and cell-type-specific activation of genomic target genes upon adenoviral transgene delivery.

Authors:  Ronni Nielsen; Lars Grøntved; Hendrik G Stunnenberg; Susanne Mandrup
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

2.  Specific unsaturated fatty acids enforce the transdifferentiation of human cancer cells toward adipocyte-like cells.

Authors:  Antonio Ruiz-Vela; Cristóbal Aguilar-Gallardo; Ana M Martínez-Arroyo; Mario Soriano-Navarro; Verónica Ruiz; Carlos Simón
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

Review 3.  Pleiotropic role of PPARγ in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB.

Authors:  Xiu-Rong Zhao; Nicole Gonzales; Jaroslaw Aronowski
Journal:  CNS Neurosci Ther       Date:  2014-11-28       Impact factor: 5.243

4.  The relationship among brain natriuretic peptide (BNP), cholesterol and lipoprotein.

Authors:  Hidekazu Takeuchi; Masataka Sata
Journal:  Heart Asia       Date:  2012-01-01

Review 5.  N-3 vs. saturated fatty acids: effects on the arterial wall.

Authors:  S Sudheendran; C C Chang; R J Deckelbaum
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-03-06       Impact factor: 4.006

6.  Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/- mice.

Authors:  Chuchun L Chang; Claudia Torrejon; Un Ju Jung; Kristin Graf; Richard J Deckelbaum
Journal:  Atherosclerosis       Date:  2014-04-03       Impact factor: 5.162

Review 7.  Metabolic and additional vascular effects of thiazolidinediones.

Authors:  Fabrice M A C Martens; Frank L J Visseren; Jacinthe Lemay; Eelco J P de Koning; Ton J Rabelink
Journal:  Drugs       Date:  2002       Impact factor: 9.546

8.  Identification and regulation of novel PPAR-gamma splice variants in human THP-1 macrophages.

Authors:  Ye Chen; Anna R Jimenez; Jheem D Medh
Journal:  Biochim Biophys Acta       Date:  2006-02-13

Review 9.  n-3 Fatty acids and cardiovascular disease: actions and molecular mechanisms.

Authors:  C Torrejon; U J Jung; R J Deckelbaum
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2007-12-03       Impact factor: 4.006

10.  n-3 fatty acids reduce arterial LDL-cholesterol delivery and arterial lipoprotein lipase levels and lipase distribution.

Authors:  Chuchun L Chang; Toru Seo; Mika Matsuzaki; Tilla S Worgall; Richard J Deckelbaum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-02-05       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.